Logo

City of Hope To Use Sequenom's MassArray Platform

Jul 19, 2006
NEW YORK (GenomeWeb News) - The City of Hope National Medical Center has purchased Sequenom's MassArray genetic analysis system and portfolio of application tools, Sequenom said today.
 
City of Hope will use MassArray for its molecular marker research and individualized cancer care initiatives, the company said.
 
Garry Larson, an associate research scientist at City of Hope, said in a statement that the center will use Sequenom's platform for quantitative gene expression and methylation studies.
 
Larson added that the center will use the genotyping system "as an integral part of our ongoing research both to identify individuals at high risk for developing cancer, and to aid in the development of therapeutic modalities based on the unique genetic profile of a given patient."
 
Financial details of the purchase were not disclosed.

Breaking News
The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.